SCRS Talks

AI at Your Site: Compliance and What It Takes

AI is moving fast, and research sites are feeling the pressure to keep up. But before diving in, there are some foundational questions every site should be asking. Jimmy sits down with Marc Wartenberger, VP of Compliance and Security at CRIO, to break down what a defensible AI validation approach actually looks like, why under-documentation is the most common compliance mistake sites are making right now, and what the January 2026 FDA and EMA joint guidance means for day-to-day site operations. If your site is anywhere on the AI journey, this one is worth your time.

From Reactive to Real-Time: How AI Is Reshaping Clinical Trial Operations

Josh Stent, CEO of Momentum Clinical Research, joins Jimmy Bechtel to share how his 19-site network in Australia and New Zealand is using AI and automation to cut administrative burden, improve data accuracy, and get more time back for patients. From centralized data reporting to automated invoicing and smarter recruitment funnels, this episode breaks down what practical AI adoption actually looks like at the site level.

Rethinking Rare Disease: Innovation and What's Next

The rare disease space is often overlooked, but it may be the most important laboratory we have for the future of medicine. Jimmy sits down with Rob Freishtat, board member of the Foundation for mRNA Medicines, to talk about what is actually driving collaboration between academic institutions and industry, what a changing regulatory landscape means for sites, and why financial viability and patient access are not as opposed as people think. Tune in now.

Built by Sites, For Sites: How Site Centric is Rethinking Clinical Trial Technology

What happens when a research site gets so frustrated with disconnected systems that they decide to build their own? In this episode, Jimmy Bechtel sits down with Brian Hunter, COO, and Florin Petrutiu, CIO of Site Centric, to hear exactly that story. Born out of CNS Healthcare over 18 years ago, Site Centric has evolved from an internal workaround into a full CTMS platform now available to sites everywhere. Brian and Florin share how their hands-on site experience shaped every corner of the platform, how they're integrating AI tools without adding operational burden, and why becoming an SCRS Global Impact Partner felt like a natural next step.

Building a Sponsor of Choice: How Keenova is Redefining Site Partnership

What does it actually mean to be a sponsor of choice? In this episode, Jimmy Bechtel sits down with Carrie Lewis and Suzy Montanye from Keenova to find out. The two share how the newly formed company, born from the merger of Mallinckrodt and Endo, is building a site partnership model grounded in accountability, transparency, and real feedback. From their site operational advisory board to a dedicated site relationship manager role, Keenova is making the case that mid-sized sponsors can operate like industry leaders.